SiS Weekly Scoop #51

💰 Future Family Secures $400M Financing Program from Clear Haven Capital

A game-changer in U.S. fertility care, this $400M financing deal promises to make family-building more accessible.

| 🔗 Read More

"This new funding helps us remove financial barriers so more women and couples can get the fertility treatments they need when they need them" – Claire Tomkins, Founder of Future Family

AstraZeneca & Daiichi’s Enhertu Gains European Commission Approval for HR-Positive Breast Cancer Treatment

A major approval in breast cancer care, offering new hope for HR-positive breast cancer patients across Europe.

| 🔗 Read More

🇨🇭 Affidea Doubles Its Swiss Footprint by Acquiring Uroviva, Creating a Leading Oncology Platform

A strategic acquisition that strengthens Affidea’s position in oncology across Switzerland.

| 🔗 Read More

“[It] is a defining moment in Affidea Group’s journey to building a comprehensive, high-quality cancer care network in Europe,” – Dr Charles Niehaus, Executive Director, Affidea.

📱 Moody Month Launches First-Ever App Mode Focused on Mental Health and Pregnancy Loss

A pioneering app designed to support women navigating the mental health challenges of pregnancy loss.

| 🔗 Read More

Cigna HealthCare & Carrot Fertility Launch Global Benefits Program to Expand Family-Building Access

A bold step towards inclusive family-building solutions, expanding benefits access worldwide.

| 🔗 Read More

“This collaboration will bring critical services and support to more people ranging from preconception through menopause.” – Tammy Sun, Founder & CEO, Carrot Fertility

🪽 Meghan Markle Makes New Angel Investment in Women’s Health Startup Midi

The Duchess of Sussex backs women’s health innovation with her latest investment in Midi, a fertility startup.

| 🔗 Read More

Michele Kang Deepens Investment in Women’s Soccer, Reaffirming Her Commitment to the US Spirit Team

A bold move that underscores Kang’s dedication to both women’s sports and women’s empowerment.
| 🔗 Read More

Another major week for women’s health innovation, investment, and disruption. 👏